MYH9 is associated with nondiabetic end-stage renal disease in African AmericansW.H. Linda Kao, Rulan S. Parekh, Michael J. Klag et al.|Nature Genetics|2008Cited by 648
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approachCrystal A. Gadegbeku, Matthias Kretzler, Keisha L. Gibson et al.|Kidney International|2013Cited by 350
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H. Rovin, Catarina Almeida, Jonathan Barratt et al.|The Lancet|2023Cited by 264
Development and evaluation of deep learning–based segmentation of histologic structures in the kidney cortex with multiple histologic stainsCatherine Jayapandian, Frank Modersitzki, Yijiang Chen et al.|Kidney International|2020Cited by 194
An eQTL Landscape of Kidney Tissue in Human Nephrotic SyndromeChristopher E. Gillies, Duncan B. Johnstone, Rosemary Putler et al.|The American Journal of Human Genetics|2018Cited by 184